Briefing.com vahendusel:
Ülespoole avanevad:
In reaction to strong earnings/guidance: NEWP +17.5%, IRBT +13.4%, SKX +10.8%, WIRE +9.4%, ITRI +8.8%, QLTY +8.2% (light volume), LOGI +8.0%, TER +7.7%, ENTR +7.3% (also upgraded to Buy at The Benchmark Company), CTXS +6.9% (also upgraded to Buy from Hold at Deutsche Bank, upgraded to Outperform at Robert W. Baird, upgraded to Neutral from Underperform at Cowen), IMAX +6.8% (light volume), OII +6.6%, CML +6.4% (also upgraded to Hold from Sell at Canaccord), TEF +5.2%, BT +4.3%, CLRT +4.0%, DRYS +2.4%, NUS +2.4% (light volume), GT +2.3%, MOT +2.2%, GMCR +2.2%, CTHR +2.1% (light volume), AZN +1.9% (also the FDA Advisory Committee recommends US FDA approval of Brilinta (Ticagrelor) for acute coronary syndromes), MPWR +1.8% (also upgraded to Strong Buy from Buy at Needham), XOM +0.7%.
M&A news: HTZ +1.0% (ticking higher after Avis Budget submits bid for Dollar Thrifty Automotive Group of $46.50 per share).
Select financial related names showing strength: ING +3.8%, UBS +3.0%, CS +2.6%, IRE +2.5%, DB +2.3%, BCS +1.8%, HBC +1.5%.
Select metals/mining stocks trading higher: RTP +2.1%, BBL +1.9%, BHP +1.8%, GOLD +1.2%, ACH +0.7%.
Select oil/gas related names showing strength: SDRL +2.2% (ticking higher), LLEN +2.2%, TOT +2.0%, CHK +1.3%, RIG +1.0%, BP +0.9%.
Other news: VCBI +17.2% (announces withdrawal of common stock offering ), ATHX +12.3% (announces positive results from Phase I study of Multistem in heart attack patients), CLNE +5.8%, FSYS +4.6% and WPRT +4.3% (Cramer makes positive comments on MadMoney), GENZ +3.4% (Genzyme trades to $70.65 in extended trading after WSJ reports on its website that Sanofi is "increasingly likely" to make a formal takeover bid to GENZ's board), SNN +2.2% (still checking), DNDN +1.8% (announces Provenge demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: VPRT -27.4%(also downgraded to Hold from Buy at Citigroup, downgraded to Mkt Perform at Barrington Research, downgraded to Neutral from Buy at Janney Montgomery Scott), CVD -14.7%, CTV -11.4%, PMI -10.2%, ARRS -9.5%, BG -9.2%, NENG -9.0%, GSIC -8.1%, SYMC -7.8%(also downgraded by multiple analysts), LOGM -7.7%, AKAM -7.1%, CRI -6.2%, NVDA -6.2%, GMR -5.9%, NETL -5.5%, LSI -5.3%, CNQR -5.0%, ASIA -4.4%, CL -4.0%, K -3.8%, DRIV -3.5%, ESRX -3.4%, NLY -3.1%, FLS -2.9%, ANH -2.8%(also downgraded to Neutral from Buy at Sterne Agee), CMO -2.3%(also downgraded to Hold from Buy at Deutsche Bank), PSSI -2.2%(light volume), CLF -2.1%, STO -1.3%.
Other news: DSTI -13.2%(discloses several investors entered into Purchase Agreements), RDN -3.3% (ticking lower following PMI results).
Analyst cldomments: AMD -1.1%(downgraded to Market Perform from Outperform at FBR Capital).